Intelligent Health-Tech Solutions for Women’s Fertility Health.
VisOvum is at the forefront of providing intelligent health-tech solutions for women’s fertility health.
About VisOvum
VisOvum is
Self-Use
Creating a state-of-the-art ‘home-self-use’ device to support the 48.5 million couples experiencing fertility challenges and to provide pelvic health insights to the 1.9 billion reproductive-age women globally.
VisOvum is
cost-effective
Individuals aspiring to conceive and gain insights into their fertility health will find value in VisOvum’s cost-effective fertility device. This tool supports their journey to pregnancy, reducing costs and time investments associated with current fertility options
VisOvum is
advanced
Integrated, AI-driven technology with Wi-Fi delivers automated IVF and gynaecology capabilities at home, guiding self-users through usage and providing immediate 'real-time' results on mobile devices.
VisOvum's USP
- Holistic Intelligent Fertility and Gynaecology care service on the go.
- Clinical capabilities directly into to the home for personal self-use
- Single Device, Multiple capabilities
- Eliminates the need for telemed or sophisticated training
- Alleviating hospital waiting demands
- Moving away from the clinical look, the VisOvum concept is designed with ergonomics in mind, ensuring effortless self-use and convenient portability. It easily fits into a handbag, offering discreet and accessible fertility monitoring on the go.
Early diagnosis and effective treatment for women is important in alleviating the global economic burden.
Gynaecology – Global Economic Burden (Annually)
INCREDIBLE OPPORTUNITY TO DISRUPT THE $37 BILLION FERTILITY MARKET
With promising results from small-scale AI testing and a prototype hardware design, we invite you to join us in refining these findings for commercial application through your funding support. This investment will provide us a 2-year runway to penetrate the lucrative market, facilitating the expansion of our operations and the introduction of our innovative solution to a broader audience.
- U.S published Patent (Pending)
- SEIS and EIS advance assurance
VisOvum’s Medical board
Dr Thanos Papthanasiou
MD (London) FRCOG FHEACEO
CEO & Medical Director Bourn Halll Fertility Clinic
Product Development Team & Business Partners
Request More Information
Simply enter your details below and a member of our board will be in touch to discuss more with you.
FOR INVESTORS
VisOvum acknowledges the increasing demand for personalised, at-home fertility healthcare solutions. Our aim is to empower individuals, couples, and healthcare providers by providing insights into fertility health while alleviating hospital waiting demands and costs.
At VisOvum we are poised to develop within 2 years aggressive expansion over the next 4 years, aiming to reach both domestic and international markets, facilitated by strategic partnerships and continuous innovation.
- U.S published Patent (Pending)
- SEIS and EIS advance assurance